Related Experiment Videos

Controlled trial of new formulae for feeding low birth weight infants

Early Human Development
|February 1, 1986
PubMed

Insights

Prematalac (Group B) significantly increased infant weight gain compared to other formulas and expressed breast milk (EBM). This enhanced weight gain in preterm infants may be linked to higher sodium intake.

Area of Science:

  • Neonatal nutrition
  • Pediatric gastroenterology
  • Infant growth studies

Background:

  • Premature infants require specialized nutrition for optimal growth.
  • Different infant formulas are available, each with unique nutritional profiles.
  • Assessing the impact of specific formulas on infant growth is crucial.

Purpose of the Study:

  • To compare the effects of three specialized infant formulas (SMA Low Birth Weight, Prematalac, Preaptamil) and expressed breast milk (EBM) on the growth of preterm infants.
  • To evaluate weight gain, linear growth, and head circumference in relation to different feeding regimens.

Main Methods:

  • Randomized controlled trial involving 85 preterm infants over 13 months.
  • Infants were allocated to four groups: SMA Low Birth Weight, Prematalac, Preaptamil, or EBM.
  • Growth parameters (weight, length, occipito-frontal circumference) were monitored until infants reached >2.0 kg.

Main Results:

  • Infants fed Prematalac (Group B) exhibited the greatest weight gain compared to other groups.
  • No significant differences were observed in length gain or occipito-frontal circumference across groups.
  • Group B showed higher sodium intake and serum sodium levels, potentially explaining increased weight gain.

Conclusions:

  • Prematalac may promote superior weight gain in preterm infants compared to other tested formulas and EBM.
  • Higher sodium intake associated with Prematalac could be a key factor in enhanced weight gain.
  • Further research is needed to confirm the long-term implications of these findings.

Related Concept Videos